| Dr Robert A Irwin, MD | |
|
3215 N Northhills Blvd, Fayetteville, AR 72703-4007 | |
| (479) 713-1000 | |
| (214) 712-2487 |
| Full Name | Dr Robert A Irwin |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 3215 N Northhills Blvd, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245247535 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C-5292 (Arkansas) | Primary |
| Entity Name | Washington Regional Medical System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306801485 PECOS PAC ID: 8820995434 Enrollment ID: O20051208000082 |
News Archive
Sweetpotato, a warm-season root crop grown across the world, needs heat and humidity to flourish. In the United States, commercial sweetpotato production occurs predominantly in the southeastern states and California, while production farther north is limited. Recently, Oregon State University researchers discovered cultural practices that could help to increase sweetpotato production in the semiarid Pacific Northwest.
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert A Irwin, MD 1717 Main St, Suite 5200, Dallas, TX 75201-4612 Ph: (214) 712-2019 | Dr Robert A Irwin, MD 3215 N Northhills Blvd, Fayetteville, AR 72703-4007 Ph: (479) 713-1000 |
News Archive
Sweetpotato, a warm-season root crop grown across the world, needs heat and humidity to flourish. In the United States, commercial sweetpotato production occurs predominantly in the southeastern states and California, while production farther north is limited. Recently, Oregon State University researchers discovered cultural practices that could help to increase sweetpotato production in the semiarid Pacific Northwest.
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
› Verified 9 days ago
Dr. Dalton L Gray Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd, Suite 101, Fayetteville, AR 72703 Phone: 479-404-1010 Fax: 479-404-1011 | |
Dr. Adam F Chandler, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3215 N Northhills Blvd, Fayetteville, AR 72703 Phone: 479-463-7102 Fax: 479-463-7864 | |
Michael Osinski, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 | |
Dr. Barbara Elaine Ashe, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3215 N. North Hills Blvd., Fayetteville, AR 72703 Phone: 479-463-7902 Fax: 479-463-5345 | |
Dr. Leigh Fincher, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 525 N Garland Ave, Fayetteville, AR 72701 Phone: 479-575-4451 | |
Ryan David Mantooth, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3215 N North Hills Blvd., Fayetteville, AR 72703 Phone: 479-463-7102 Fax: 479-463-5987 | |
Dr. John C Frank, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3215 N Northhills Blvd, Fayetteville, AR 72703 Phone: 479-463-7102 Fax: 479-463-5987 |